A prospective evaluation of minimal residual disease as risk stratification for CCLG-ALL-2008 treatment protocol in pediatric B precursor acute lymphoblastic leukemia

Hu Y. -X.; Lu J.; He H. -L.; Wang Y.; Li J. -Q.; Xiao P. -F.; Li J.; Lv H.; Sun Y. -N.; Fan J. -J.; Chai Y. -H.; Hu S. -Y.

首页> 外文期刊>European review for medical and pharmacological sciences. >A prospective evaluation of minimal residual disease as risk stratification for CCLG-ALL-2008 treatment protocol in pediatric B precursor acute lymphoblastic leukemia

【24h】

A prospective evaluation of minimal residual disease as risk stratification for CCLG-ALL-2008 treatment protocol in pediatric B precursor acute lymphoblastic leukemia

机译：最小残留疾病作为CCLG-ALL-2008治疗方案在小儿B前体急性淋巴细胞白血病中的风险分层的前瞻性评估

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

OBJECTIVE: The aim of this prospective study was to evaluate the cut-off value of minimal residual disease (MRD) in predicting the efficacy of CCLG-ALL-2008 or CCLG-2008 treatment protocol on pediatric B-precursor ALL (BP-ALL).

机译：目的：本前瞻性研究的目的是评估最小残留疾病（MRD）的临界值，以预测CCLG-ALL-2008或CCLG-2008治疗方案对小儿B前体ALL（BP-ALL）的疗效。

著录项

来源
《European review for medical and pharmacological sciences.》 |2016年第9期|共11页
作者
Hu Y. -X.; Lu J.; He H. -L.; Wang Y.; Li J. -Q.; Xiao P. -F.; Li J.; Lv H.; Sun Y. -N.; Fan J. -J.; Chai Y. -H.; Hu S. -Y.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类药理学;
关键词
Acute lymphoblastic leukemia (ALL); Minimal residual disease (MRD); Relapse-free survival (RFS); Event-free survival (EFS); Overall survival (OS);

机译：急性淋巴细胞白血病（ALL）;最小残留疾病（MRD）;无复发生存期（RFS）;无事件生存期（EFS）;总生存期（OS）;

相似文献

外文文献
中文文献
专利

1. A prospective evaluation of minimal residual disease as risk stratification for CCLG-ALL-2008 treatment protocol in pediatric B precursor acute lymphoblastic leukemia [J] . Hu Y. -X., Lu J., He H. -L., European review for medical and pharmacological sciences. . 2016,第9期

机译：最小残留疾病作为CCLG-ALL-2008治疗方案在小儿B前体急性淋巴细胞白血病中的风险分层的前瞻性评估
2. The clinical impact of IKZF1 deletions in paediatric B-cell precursor acute lymphoblastic leukaemia is independent of minimal residual disease stratification in Nordic Society for Paediatric Haematology and Oncology treatment protocols used between 1992 and 2013 [J] . Olsson Linda, Oefverholm Ingegerd Ivanov, Noren-Nystroem Ulrika, British Journal of Haematology . 2015,第6期

机译：IKZF1缺失在小儿B细胞前体急性淋巴细胞白血病中的临床影响与1992年至2013年间在北欧小儿血液学和肿瘤学治疗方案中使用的最小残留疾病分层无关
3. Integrated Risk Stratification Using Minimal Residual Disease and Sentinel Genetic Alterations in Pediatric Acute Lymphoblastic Leukemia [J] . Hunger Stephen P. Journal of Clinical Oncology . 2018,第1期

机译：使用最少的残余疾病和哨兵急性淋巴细胞白血病综合风险分层
4. Discrimination of minimal residual disease in acute lymphoblastic leukemia by using single-beam acoustic tweezer [C] . Hsiao-Cliuan Liu, Hye Na Kim, Enzi Jiang, IEEE International Ultrasonics Symposium . 2017

机译：用单束声镊鉴别急性淋巴细胞白血病的最小残留病
5. Somatic Mutation Detection in Leukemia-Derived Circulating DNA: Utility in Monitoring Clonal Dynamics and Disease Response in Pediatric Acute Lymphoblastic Leukemia [D] . Youssef, Sarah Hisham Abdelaziz. 2018

机译：白血病衍生循环DNA中的体细胞突变检测：小儿急性淋巴细胞白血病监测克隆动力学和疾病反应的效用
6. Lymphoid Neoplasia: Gene expression classifiers for relapse-free survival and minimal residual disease improve risk classification and outcome prediction in pediatric B-precursor acute lymphoblastic leukemia [O] . Huining Kang, I.-Ming Chen, Carla S. Wilson, -1

机译：淋巴瘤形成：无复发生存和最小残留疾病的基因表达分类器可改善小儿B前体急性淋巴细胞白血病的风险分类和结果预测
7. Gene expression classifiers for relapse-free survival and minimal residual disease improve risk classification and outcome prediction in pediatric B-precursor acute lymphoblastic leukemia [O] . Kang, Huining, Chen, I.-Ming, Wilson, Carla S., 2009

机译：用于无复发生存和最小残留疾病的基因表达分类器改善了小儿B前体急性淋巴细胞白血病的风险分类和结果预测

A prospective evaluation of minimal residual disease as risk stratification for CCLG-ALL-2008 treatment protocol in pediatric B precursor acute lymphoblastic leukemia

摘要

著录项

相似文献

相关主题

期刊订阅